Julia R. Zebol

1.1k total citations
13 papers, 932 citations indexed

About

Julia R. Zebol is a scholar working on Molecular Biology, Cell Biology and Infectious Diseases. According to data from OpenAlex, Julia R. Zebol has authored 13 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cell Biology and 1 paper in Infectious Diseases. Recurrent topics in Julia R. Zebol's work include Sphingolipid Metabolism and Signaling (13 papers), Cellular transport and secretion (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Julia R. Zebol is often cited by papers focused on Sphingolipid Metabolism and Signaling (13 papers), Cellular transport and secretion (7 papers) and Lipid Membrane Structure and Behavior (6 papers). Julia R. Zebol collaborates with scholars based in Australia and United States. Julia R. Zebol's co-authors include Stuart M. Pitson, Paul A.B. Moretti, Mathew A. Vadas, Binks W. Wattenberg, Pu Xia, Richard J. D’Andrea, Tamara Leclercq, Kate E. Jarman, Jennifer R. Gamble and Briony L. Gliddon and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Oncogene.

In The Last Decade

Julia R. Zebol

13 papers receiving 923 citations

Peers

Countries citing papers authored by Julia R. Zebol

Since Specialization

Citations

This map shows the geographic impact of Julia R. Zebol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia R. Zebol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia R. Zebol more than expected).

Fields of papers citing papers by Julia R. Zebol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia R. Zebol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia R. Zebol. The network helps show where Julia R. Zebol may publish in the future.

Co-authorship network of co-authors of Julia R. Zebol

This figure shows the co-authorship network connecting the top 25 collaborators of Julia R. Zebol. A scholar is included among the top collaborators of Julia R. Zebol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia R. Zebol. Julia R. Zebol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Kelch-like protein 5-mediated ubiquitination of lysine 183 promotes proteasomal degradation of sphingosine kinase 1 2019 ·Biochemical Journal ·Jason A. Powell, Melissa R. Pitman, Julia R. Zebol, Paul A.B. Moretti, Heidi A. Neubauer, (unknown), Alexander C. Lewis, Laura F. Dagley, Andrew I. Webb, Maurizio Costabile, Stuart M. Pitson	10
2	Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma 2018 ·Oncogene ·Heidi A. Neubauer, Melinda N. Tea, Julia R. Zebol, Briony L. Gliddon, (unknown), Paul A.B. Moretti, Melissa R. Pitman, Maurizio Costabile, Jasreen Kular, Brett W. Stringer, Bryan W. Day, Michael S. Samuel, Claudine S. Bonder, Jason A. Powell, Stuart M. Pitson	22
3	Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress 2017 ·Oncotarget ·Craig T. Wallington‐Beddoe, (unknown), Kate Vandyke, (unknown), Julia R. Zebol, Paul A.B. Moretti, Melissa R. Pitman, D. Hewett, Andrew C.W. Zannettino, Stuart M. Pitson	38
4	An oncogenic role for sphingosine kinase 2 2016 ·Oncotarget ·Heidi A. Neubauer, Duyen Pham, Julia R. Zebol, Paul A.B. Moretti, (unknown), Tamara Leclercq, (unknown), Jason A. Powell, Melissa R. Pitman, Michael S. Samuel, Claudine S. Bonder, Darren J. Creek, Briony L. Gliddon, Stuart M. Pitson	51
5	Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis 2015 ·The FASEB Journal ·(unknown), Julia R. Zebol, Katie L. Tooley, Wai Yan Sun, Lachlan M. Moldenhauer, (unknown), Briony L. Gliddon, Paul A.B. Moretti, Gábor Tigyi, Stuart M. Pitson, Claudine S. Bonder	73
6	A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties 2015 ·Oncotarget ·Melissa R. Pitman, Jason A. Powell, (unknown), Paul A.B. Moretti, Julia R. Zebol, Duyen Pham, John Finnie, Anthony S. Don, Lisa M. Ebert, Claudine S. Bonder, Briony L. Gliddon, Stuart M. Pitson	64
7	Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA 2013 ·Journal of General Virology ·Jillian M. Carr, (unknown), Jennifer N. Clarke, (unknown), Julia R. Zebol, Michael R. Beard, Stuart M. Pitson	29
8	Translocation of Sphingosine Kinase 1 to the Plasma Membrane Is Mediated by Calcium- and Integrin-binding Protein 1 2009 ·Journal of Biological Chemistry ·Kate E. Jarman, Paul A.B. Moretti, Julia R. Zebol, Stuart M. Pitson	122
9	The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1 2008 ·The International Journal of Biochemistry & Cell Biology ·Julia R. Zebol, (unknown), Paul A.B. Moretti, (unknown), (unknown), Peng Li, Mathew A. Vadas, Binks W. Wattenberg, Stuart M. Pitson	15
10	Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling 2004 ·The Journal of Experimental Medicine ·Stuart M. Pitson, Pu Xia, Tamara Leclercq, Paul A.B. Moretti, Julia R. Zebol, (unknown), Binks W. Wattenberg, Mathew A. Vadas	230
11	The Nucleotide-binding Site of Human Sphingosine Kinase 1 2002 ·Journal of Biological Chemistry ·Stuart M. Pitson, Paul A.B. Moretti, Julia R. Zebol, Reza Zareie, Claudia K. Derian, Andrew L. Darrow, Jenson Qi, Richard J. D’Andrea, Christopher J. Bagley, Mathew A. Vadas, Binks W. Wattenberg	90
12	A point mutant of human sphingosine kinase 1 with increased catalytic activity 2001 ·FEBS Letters ·Stuart M. Pitson, Paul A.B. Moretti, Julia R. Zebol, Mathew A. Vadas, Richard J. D’Andrea, Binks W. Wattenberg	16
13	Expression of a Catalytically Inactive Sphingosine Kinase Mutant Blocks Agonist-induced Sphingosine Kinase Activation 2000 ·Journal of Biological Chemistry ·Stuart M. Pitson, Paul A.B. Moretti, Julia R. Zebol, Pu Xia, Jennifer R. Gamble, Mathew A. Vadas, Richard J. D’Andrea, Binks W. Wattenberg	172

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact